SMAD4 and neoplasm: While 18q22.1 event involves the loss of SMAD4, a potent tumor suppressor and modulator of TGF-Beta signaling pathway22, 11q21.2 amplification strongly elevates the expression of the potent proto-oncogene YAP1 and inhibitors of apoptosis BIRC2-3.